{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:20:23Z","timestamp":1783783223435,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"DOI":"10.1007\/s12024-024-00879-4","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:02:44Z","timestamp":1727449364000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hereditary thrombophilia as a possible risk factor for severe disease in COVID-19: a case series"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9384-4131","authenticated-orcid":false,"given":"Jonathan","family":"Tse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julita","family":"Gongolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Prahlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"4","key":"879_CR1","first-page":"469","volume":"28","author":"J Rashedi","year":"2020","unstructured":"Rashedi J, Mahdavi Poor B, Asgharzadeh V, et al. Risk factors for COVID-19. Infez Med. 2020;28(4):469\u201374.","journal-title":"Infez Med"},{"key":"879_CR2","unstructured":"People with certain medical conditions. In: COVID-19. Centers for Disease Control and Prevention. Published 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html. Accessed 5 Dec 2023."},{"key":"879_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620962853","author":"A \u200cKichloo","year":"2020","unstructured":"\u200cKichloo A, Dettloff K, Aljadah M, et al. COVID-19 and hypercoagulability: a review. Clin Appl Thromb Hemost. 2020. https:\/\/doi.org\/10.1177\/1076029620962853.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"879_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/02683555211052170","volume":"37","author":"NM Cheng","year":"2022","unstructured":"Cheng NM, Chan YC, Cheng SW. COVID-19 related thrombosis: a mini-review. Phlebology. 2022;37(5):326\u201337. https:\/\/doi.org\/10.1177\/02683555211052170.","journal-title":"Phlebology"},{"issue":"3","key":"879_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11239-022-02766-7","volume":"55","author":"M Zuin","year":"2023","unstructured":"Zuin M, Barco S, Giannakoulas G, et al. Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis. 2023;55(3):490\u20138. https:\/\/doi.org\/10.1007\/s11239-022-02766-7.","journal-title":"J Thromb Thrombolysis"},{"key":"879_CR6","doi-asserted-by":"publisher","first-page":"175501","DOI":"10.1016\/j.ejphar.2023.175501","volume":"941","author":"GP Massoud","year":"2023","unstructured":"Massoud GP, Hazimeh DH, Amin G, et al. Risk of thromboembolic events in non-hospitalized COVID-19 patients: a systematic review. Eur J Pharmacol. 2023;941:175501. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175501.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"879_CR7","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/archsurg.1982.01380330064015","volume":"117","author":"HB Wheeler","year":"1982","unstructured":"Wheeler HB, Anderson FA Jr, Cardullo PA, Patwardhan NA, Jian-Ming L, Cutler BS. Suspected deep vein thrombosis. Management by impedance plethysmography. Arch Surg. 1982;117(9):1206\u20139. https:\/\/doi.org\/10.1001\/archsurg.1982.01380330064015.","journal-title":"Arch Surg"},{"issue":"23 Suppl 1","key":"879_CR8","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","volume":"107","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9\u201316. https:\/\/doi.org\/10.1161\/01.CIR.0000078469.07362.E6.","journal-title":"Circulation"},{"key":"879_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104362","author":"D Giannis","year":"2020","unstructured":"Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020. https:\/\/doi.org\/10.1016\/j.jcv.2020.104362.","journal-title":"J Clin Virol"},{"key":"879_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0188","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020. https:\/\/doi.org\/10.1515\/cclm-2020-0188.","journal-title":"Clin Chem Lab Med"},{"key":"879_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.06.029","author":"MY Abou-Ismail","year":"2020","unstructured":"Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management [published correction appears in Thromb Res. 2020]. Thromb Res. 2020. https:\/\/doi.org\/10.1016\/j.thromres.2020.06.029.","journal-title":"Thromb Res"},{"issue":"1","key":"879_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5455\/medarh.2022.76.62-65","volume":"76","author":"EW Ali","year":"2022","unstructured":"Ali EW, Ibrahim IK. Multi-factorial mechanism behind COVID-19 related thrombosis. Med Arch. 2022;76(1):62\u20135. https:\/\/doi.org\/10.5455\/medarh.2022.76.62-65.","journal-title":"Med Arch"},{"issue":"12","key":"879_CR13","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/ajh.25982","volume":"95","author":"TC Hanff","year":"2020","unstructured":"Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95(12):1578\u201389. https:\/\/doi.org\/10.1002\/ajh.25982.","journal-title":"Am J Hematol"},{"issue":"12","key":"879_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/crj.13438","volume":"15","author":"M Sarkar","year":"2021","unstructured":"Sarkar M, Madabhavi IV, Quy PN, Govindagoudar MB. COVID-19 and coagulopathy. Clin Respir J. 2021;15(12):1259\u201374. https:\/\/doi.org\/10.1111\/crj.13438.","journal-title":"Clin Respir J"},{"key":"879_CR15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1311791","author":"T Baglin","year":"2012","unstructured":"Baglin T. Inherited and acquired risk factors for venous thromboembolism. Semin Respir Crit Care Med. 2012. https:\/\/doi.org\/10.1055\/s-0032-1311791.","journal-title":"Semin Respir Crit Care Med"},{"key":"879_CR16","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000839","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Jin Y, Li X, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G\/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review. Vasa. 2020. https:\/\/doi.org\/10.1024\/0301-1526\/a000839.","journal-title":"Vasa"},{"key":"879_CR17","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2013-1124","author":"GK Nikolopoulos","year":"2014","unstructured":"Nikolopoulos GK, Bagos PG, Tsangaris I, et al. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G\/5G polymorphism, and myocardial infarction: a mendelian randomization meta-analysis. Clin Chem Lab Med. 2014. https:\/\/doi.org\/10.1515\/cclm-2013-1124.","journal-title":"Clin Chem Lab Med"},{"key":"879_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.06.040","author":"Y Liu","year":"2018","unstructured":"Liu Y, Cheng J, Guo X, et al. The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: a systematic review and meta-analysis involving 149,908 subjects. Gene. 2018. https:\/\/doi.org\/10.1016\/j.gene.2018.06.040.","journal-title":"Gene"},{"key":"879_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124562","author":"S Raghubeer","year":"2021","unstructured":"Raghubeer S, Matsha TE. Methylenetetrahydrofolate (MTHFR), the one-Carbon cycle, and Cardiovascular risks. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13124562.","journal-title":"Nutrients"},{"key":"879_CR20","unstructured":"Dean L. Methylenetetrahydrofolate Reductase Deficiency. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, eds. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); March 8, 2012."},{"key":"879_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.22.2113","author":"F Nappo","year":"1999","unstructured":"Nappo F, De Rosa N, Marfella R, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA. 1999. https:\/\/doi.org\/10.1001\/jama.281.22.2113.","journal-title":"JAMA"},{"key":"879_CR22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11611","author":"WM Lijfering","year":"2007","unstructured":"Lijfering WM, Veeger NJ, Brouwer JL, van der Meer J. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels. Haematologica. 2007. https:\/\/doi.org\/10.3324\/haematol.11611.","journal-title":"Haematologica"},{"key":"879_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612.pub5","author":"AJ Mart\u00ed-Carvajal","year":"2017","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD006612.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"879_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.19.2101","author":"JG Ray","year":"1998","unstructured":"Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998. https:\/\/doi.org\/10.1001\/archinte.158.19.2101.","journal-title":"Arch Intern Med"},{"key":"879_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy004","author":"M Ospina-Romero","year":"2018","unstructured":"Ospina-Romero M, Cannegieter SC, den Heijer M, Doggen CJM, Rosendaal FR, Lijfering WM. Hyperhomocysteinemia and risk of first venous thrombosis: the influence of (unmeasured) confounding factors. Am J Epidemiol. 2018. https:\/\/doi.org\/10.1093\/aje\/kwy004.","journal-title":"Am J Epidemiol"},{"key":"879_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.181","author":"S Alizadeh","year":"2016","unstructured":"Alizadeh S, Djafarian K, Moradi S, Shab-Bidar S. C667T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene and susceptibility to myocardial infarction: a systematic review and meta-analysis. Int J Cardiol. 2016. https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.181.","journal-title":"Int J Cardiol"},{"key":"879_CR27","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200860","author":"M Gao","year":"2020","unstructured":"Gao M, Feng N, Zhang M, Ti X, Zuo X. Meta-analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the caucasian and Asian. Biosci Rep. 2020. https:\/\/doi.org\/10.1042\/BSR20200860.","journal-title":"Biosci Rep"},{"key":"879_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2014.02.046","author":"E Simsek","year":"2014","unstructured":"Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT. Combined genetic mutations have remarkable effect on deep venous thrombosis and\/or pulmonary embolism occurrence. Gene. 2014. https:\/\/doi.org\/10.1016\/j.gene.2014.02.046.","journal-title":"Gene"},{"key":"879_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-016-9956-7","author":"BL Levin","year":"2016","unstructured":"Levin BL, Varga E. MTHFR: addressing genetic counseling dilemmas using evidence-based literature. J Genet Couns. 2016. https:\/\/doi.org\/10.1007\/s10897-016-9956-7.","journal-title":"J Genet Couns"},{"key":"879_CR30","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010177","author":"S Middeldorp","year":"2023","unstructured":"Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al. American Society of Hematology 2023 Guidelines for Management of venous thromboembolism: Thrombophilia Testing [published online ahead of print, 2023 May 17]. Blood Adv. 2023. https:\/\/doi.org\/10.1182\/bloodadvances.2023010177.","journal-title":"Blood Adv"},{"issue":"6","key":"879_CR31","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/healthcare10060993","volume":"10","author":"OV Badulescu","year":"2022","unstructured":"Badulescu OV, Sirbu PD, Filip N, et al. Hereditary Thrombophilia in the era of COVID-19. Healthc (Basel). 2022;10(6):993. https:\/\/doi.org\/10.3390\/healthcare10060993. Published 2022 May 27.","journal-title":"Healthc (Basel)"},{"key":"879_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.thromres.2022.08.020","volume":"218","author":"M Kovac","year":"2022","unstructured":"Kovac M, Mitic G, Milenkovic M, et al. Thrombosis risk assessment in patients with congenital thrombophilia during COVID \u2013\u200919 infection. Thromb Res. 2022;218:151\u20136. https:\/\/doi.org\/10.1016\/j.thromres.2022.08.020.","journal-title":"Thromb Res"},{"key":"879_CR33","doi-asserted-by":"publisher","unstructured":"Elbadry MI, Tawfeek A, Abdellatif MG et al. Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia [published correction appears in Br J Haematol. 2022;198(1):214. https:\/\/doi.org\/10.1111\/bjh.18301. Br J Haematol. 2022;196(4):902\u2013922. doi:https:\/\/doi.org\/10.1111\/bjh.17986.","DOI":"10.1111\/bjh.18301 10.1111\/bjh.17986"}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-024-00879-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12024-024-00879-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-024-00879-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T23:51:47Z","timestamp":1743378707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12024-024-00879-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1007\/s12024-024-00879-4","relation":{},"ISSN":["1556-2891"],"issn-type":[{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"14 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest and source funding"}},{"value":"No competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}